Citation: P. Gorog et Ib. Kovacs, INHIBITION OF VASCULAR SMOOTH-MUSCLE CELL-MIGRATION BY INTACT ENDOTHELIUM IS NITRIC OXIDE-MEDIATED - INTERFERENCE BY OXIDIZED LOW-DENSITY LIPOPROTEINS, Journal of vascular research, 35(3), 1998, pp. 165-169
Citation: Ib. Kovacs et al., ASSESSMENT OF HEMOSTATIC STATUS OF PATIENTS WITH MYELOPROLIFERATIVE DISORDERS BY HAEMOSTATOMETRY, Thrombosis and haemostasis, 1997, pp. 183-183
Citation: Kj. Pasi et al., AURIN TRICARBOXYLIC-ACID INDUCED DEFECTS IN HEMOSTASIS MIMIC VON-WILLEBRANDS-DISEASE AND CAN BE CORRECTED BY ADDITION OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 1997, pp. 880-880
Citation: P. Gorog et al., ELEVATED PLASMA OXIDIZED LDL IN CORONARY-ARTERY DISEASE - A POSSIBLE MECHANISM OF PLATELET HYPERREACTIVITY, Thrombosis and haemostasis, 1997, pp. 1057-1057
Authors:
KOVACS IB
JAHANGIRI M
RIDLER CD
GOROG P
REES GM
Citation: Ib. Kovacs et al., PERIOPERATIVE LIPID MODIFICATIONS MAY EXPLAIN THROMBOTIC AND FIBRINOLYTIC COMPLICATIONS FOLLOWING CORONARY-ARTERY BYPASS-GRAFTING, Thrombosis and haemostasis, 1997, pp. 1337-1337
Citation: Cd. Ridler et al., DEVELOPMENT OF AN IN-VITRO SYSTEM FOR THE ASSESSMENT OF THE HEMOSTATIC EFFICACY OF BLOOD PRODUCTS USED FOR THE TREATMENT OF VWD, Thrombosis and haemostasis, 1997, pp. 2606-2606
Authors:
HARRISON AP
KIRBY JDT
RIDLER CD
KOVACS IB
Citation: Ap. Harrison et al., EFFECT OF HORMONE REPLACEMENT THERAPY (HRT) ON THE HEMOSTATIC STATUS OF PATIENTS WITH SYSTEMIC-SCLEROSIS, Thrombosis and haemostasis, 1997, pp. 3012-3012
Citation: Ib. Kovacs et al., ELEVATED PLASMA-LIPID HYDROPEROXIDES IN PATIENTS WITH CORONARY-ARTERYDISEASE, The American heart journal, 134(3), 1997, pp. 572-576
Citation: Da. Gorog et Ib. Kovacs, SHEAR-INDUCED PLATELET-AGGREGATION HAS PATHOLOGICAL SIGNIFICANCE THROUGH THROMBIN GENERATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1046-1046
Citation: Ib. Kovacs et al., MONITORING POTENCY OF FACTOR-VIII-REPLACEMENT IN RESTORING HEMOSTATICCOMPETENCE IN-VITRO AND IN-VIVO, Thrombosis and haemostasis, 73(6), 1995, pp. 1172-1172
Citation: Cd. Ridler et Ib. Kovacs, DETERMINANTS OF THE RATE OF COAGULATION OF FLOWING BLOOD IN-VITRO, Thrombosis and haemostasis, 73(6), 1995, pp. 1234-1234
Citation: M. Jahangiri et al., FACTORS CONTRIBUTING TO ATHEROGENIC LIPID MODIFICATION DURING AND AFTER CORONARY-ARTERY BYPASS-SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 1395-1395
Citation: P. Gorog et Ib. Kovacs, CONTRIBUTION OF PLATELETS TO PEROXIDATION OF PLASMA-LIPIDS DURING THROMBOTIC REACTION, Thrombosis and haemostasis, 73(6), 1995, pp. 1395-1395
Citation: Da. Gorog et Ib. Kovacs, THROMBOTIC STATUS ANALYZER - MEASUREMENT OF PLATELET-RICH THROMBUS FORMATION AND LYSIS IN NATIVE BLOOD, Thrombosis and haemostasis, 73(3), 1995, pp. 514-520
Citation: P. Gorog et Ib. Kovacs, LIPID-PEROXIDATION BY ACTIVATED PLATELETS - A POSSIBLE LINK BETWEEN THROMBOSIS AND ATHEROGENESIS, Atherosclerosis, 115(1), 1995, pp. 121-128
Citation: Kj. Pasi et al., DEVELOPING A SHEAR-STRESS MODEL SYSTEM TO ASSESS POTENTIAL EFFICACY OF BLOOD PRODUCTS USED FOR TREATMENT OF VON-WILLEBRAND DISEASE, Blood, 86(10), 1995, pp. 3522-3522
Citation: Ib. Kovacs et al., ADDITION OF NIFEDIPINE TO ASPIRIN IMPROVES PLATELET REACTIVITY IN CARDIAC PATIENTS WHO FAIL TO RESPOND TO ASPIRIN ALONE, Thrombosis and haemostasis, 69(6), 1993, pp. 634-634
Citation: Lch. John et al., INHIBITION OF PLATELET-FUNCTION BY HEPARIN - AN ETIOLOGIC FACTOR IN POST BYPASS HEMORRHAGE, Thrombosis and haemostasis, 69(6), 1993, pp. 1070-1070
Citation: Lch. John et al., REDUCED BINDING TO AND INHIBITION OF PLATELETS BY HEPARIN - A POSSIBLE HEMOSTATIC ACTION FOR APROTININ IN CARDIAC-SURGERY, Thrombosis and haemostasis, 69(6), 1993, pp. 1289-1289
Authors:
YAMAMOTO J
ISHII I
OKADA Y
YAMASHITA T
RIDLER CD
GOROG P
KOVACS IB
Citation: J. Yamamoto et al., EFFECT OF LEUKOCYTE PRODUCTS ON PLATELET THROMBUS FORMATION, COAGULATION AND SPONTANEOUS THROMBOLYSIS, AS MEASURED FROM NATIVE HUMAN BLOOD,IN-VITRO, Thrombosis research, 71(4), 1993, pp. 281-287
Citation: Lch. John et al., APROTININ - AN ALTERNATIVE EXPLANATION FOR THE OBSERVED EFFECT ON GLYCOPROTEIN-IB LEVELS, Journal of thoracic and cardiovascular surgery, 106(4), 1993, pp. 747-748
Citation: Lch. John et al., INHIBITION OF PLATELET-FUNCTION BY HEPARIN - AN ETIOLOGIC FACTOR IN POSTBYPASS HEMORRHAGE, Journal of thoracic and cardiovascular surgery, 105(5), 1993, pp. 816-822
Citation: Lch. John et al., DIFFERENT ANTICOAGULANTS AND PLATELET REACTIVITY IN CARDIAC SURGICAL PATIENTS, The Annals of thoracic surgery, 56(4), 1993, pp. 899-902
Citation: Lch. John et al., REDUCTION OF HEPARIN-BINDING TO AND INHIBITION OF PLATELETS BY APROTININ, The Annals of thoracic surgery, 55(5), 1993, pp. 1175-1179